Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Relistor

- PMLiVE

Valeant and Shire said to be evaluating potential Salix bids

Valeant currently in final stages of Provenge acquisition

- PMLiVE

Deal Watch table for January 2015

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Pharma deals during January 2015

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Takeda’s ‘oral Velcade’ clears first phase III hurdle

Ixazomib shows early stage promise for myeloma

Searching for junk

The pharma industry might be focusing on the wrong acquisitions

- PMLiVE

Valeant lead bidder for troubled Dendreon

Willing to pay $296m for company behind prostate cancer vaccine Provenge

Pharma deals during December 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for December 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

NICE set to dismiss Millennium’s Crohn’s drug Entyvio

Body cites uncertain evidence and unlikely value for the NHS

Pharma deals during November 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for November 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Otsuka expands CNS presence with Avanir purchase

Deal for US biotech is valued at $3.5bn

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links